A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
Dylan R. Rivas(University of Kentucky), Jessica S. Blackburn(University of Kentucky)
Cited by 15
Related Papers
Small Extracellular Vesicles from Radioresistant H3K27M-Pediatric Diffuse Midline Glioma Cells Modulate Tumor Phenotypes and Radiation Response
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1
Small Extracellular Vesicles From Radioresistant H3K27M‐Pediatric Diffuse Midline Glioma Cells Modulate Tumor Phenotypes and Radiation Response
|Journal of Extracellular Vesicles|2025|1
Development and characterization of nanobodies specifically targeting the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3)
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0
Phosphatase activity is dispensable for PRL-3-mediated oncogenesis and tumor progression
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0